Abstract:Objectives Hypertension is an important risk factor for the development of atherosclerosis. It is associated with an activated tissue rennin–angiotensin system. But the molecular mechanisms for this interaction are incompletely defined. To get insight into a role of the class A scavenger receptor (SR-A) in hypertension enhanced atherosclerotic complications, we have investigated the effects of angiotensin II (Ang II) on SR-A expression and macrophage foam cell formation in cultured human macrophages. Design and methods The human THP-1 monocyte cell line was differentiated into macrophages in vitro and treated with Ang II (10–10 and 10–6 M), or with Ang II (10–8 M) and the angiotensin II type 1 (AT1) receptor blocker Irbesartan (10–5 M) for 24 h in the cells. Foam cell formation was quantified based on percentage of macrophage harboring oil red O-stained globules. SR-A message was measured by competitive reverse transcription-polymerase chain reaction (RT-PCR) and SR-A protein was detected by immunoblot. Results The human macrophages with various concentrations of Ang II enhanced, in a dose-and time-dependent manner, SR-A gene (3.4±0.8-fold by 10-6 M Ang II; P<0.05), and protein (2.8±0.4-fold; P<0.05) expression, reaching their maximum after 24 h incubation (14.3±1.5-fold for gene, P<0.05; 12.6±1.3-fold for protein, P<0.05, respectively); (2) The AT1 receptor blocker Irbesartan prevents these inductions; (3) The increased SR-A expression results in enhancement in the uptake of acetylated low-density lipoprotein (ac-LDL) by an AT1-dependent pathway; (4) Ang II induced human macrophage-derived foam cell formation through a SR-A-dependent pathway. Conclusions These results suggest that Ang II enhances SR-A expression in human macrophages, and that this effect is associated with foam cell formation. The induction of SR-A is mediated by the AT1 receptor. Some of the benefits of AT1 receptor blocker might be explained by their antiatherosclerotic reaction. Objectives Hypertension is an important risk factor for the development of atherosclerosis. It is associated with an activated tissue rennin–angiotensin system. But the molecular mechanisms for this interaction are incompletely defined. To get insight into a role of the class A scavenger receptor (SR-A) in hypertension enhanced atherosclerotic complications, we have investigated the effects of angiotensin II (Ang II) on SR-A expression and macrophage foam cell formation in cultured human macrophages. Design and methods The human THP-1 monocyte cell line was differentiated into macrophages in vitro and treated with Ang II (10–10 and 10–6 M), or with Ang II (10–8 M) and the angiotensin II type 1 (AT1) receptor blocker Irbesartan (10–5 M) for 24 h in the cells. Foam cell formation was quantified based on percentage of macrophage harboring oil red O-stained globules. SR-A message was measured by competitive reverse transcription-polymerase chain reaction (RT-PCR) and SR-A protein was detected by immunoblot. Results The human macrophages with various concentrations of Ang II enhanced, in a dose-and time-dependent manner, SR-A gene (3.4±0.8-fold by 10-6 M Ang II; P<0.05), and protein (2.8±0.4-fold; P<0.05) expression, reaching their maximum after 24 h incubation (14.3±1.5-fold for gene, P<0.05; 12.6±1.3-fold for protein, P<0.05, respectively); (2) The AT1 receptor blocker Irbesartan prevents these inductions; (3) The increased SR-A expression results in enhancement in the uptake of acetylated low-density lipoprotein (ac-LDL) by an AT1-dependent pathway; (4) Ang II induced human macrophage-derived foam cell formation through a SR-A-dependent pathway. Conclusions These results suggest that Ang II enhances SR-A expression in human macrophages, and that this effect is associated with foam cell formation. The induction of SR-A is mediated by the AT1 receptor. Some of the benefits of AT1 receptor blocker might be explained by their antiatherosclerotic reaction.

Urotensin II Increases Foam Cell Formation by Repressing ABCA1 Expression Through the ERK/NF-κB Pathway in THP-1 Macrophages

Angiotensin II Decreases Cholesterol 27-Hydroxylase Expression and Promotes Foam Cell Formation in THP-1

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits

Autocrine Human Urotensin II Enhances Macrophage-Derived Foam Cell Formation in Transgenic Rabbits.

Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits

Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits

Urotensin Ii Promotes Secretion Of Ltb4 Through 5-Lipoxygenase Via The Ut-Ros-Akt Pathway In Raw264.7 Macrophages

Angiotensin Ii Enhances Human Macrophage Class A Scavenger Receptor Expression And Induces Foam Cell Formation

Effects of Angiotensin II on Expression of Acyl-Coenzyme A: Cholesterol Acyltransferase-1 and Peroxisome Proliferator-Activated Receptor-Γ in Macrophages and Foam Cells

Apelin-13 Increases Expression of ATP-binding Cassette Transporter A1 Via Activating Protein Kinase C Α Signaling in THP-1 Macrophage-Derived Foam Cells.

Inhibition of ERK1/2 and Activation of Liver X Receptor Synergistically Induce Macrophage ABCA1 Expression and Cholesterol Efflux.

[Effect of Urotensin II on Proliferative Potential and Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 of Adventitial Fibroblasts from Spontaneously Hypertensive Rat].

Role of ABCA1 in Angiotensin Ⅱ-induced Cholesterol Accumulation in Podocytes

Angiotensin II induces the expression of c-reactive protein via MAPK-dependent signal pathway in U937 macrophages.

Effect of Urolithin A on Macrophage Polarization and the Formation of Macrophage-Derived Foam Cells

Angiotensin II Deteriorates Advanced Atherosclerosis by Promoting MerTK Cleavage and Impairing Efferocytosis Through the AT(1)R/ROS/p38 MAPK/ADAM17 Pathway

Influence of Angiotensin-(1-7) and Angiotensin II on Expression of NPC1 and Cholesterol Efflux in THP-1 Macrophages

Alteration of Vascular Urotensin Ii Receptor in Mice with Apolipoprotein E Gene Knockout

CTRP1 decreases ABCA1 expression and promotes lipid accumulation through the miR‐424‐5p/FoxO1 pathway in THP‐1 macrophage‐derived foam cells

Eicosapentaenoic Acid Reduces ABCA1 Serine Phosphorylation and Impairs ABCA1-dependent Cholesterol Efflux Through Cyclic AMP/protein Kinase A Signaling Pathway in THP-1 Macrophage-Derived Foam Cells.

Apelin-13 Impedes Foam Cell Formation by Activating Class Iii Pi3k/Beclin-1-Mediated Autophagic Pathway